Business Context and Reporting Period
This Form 8-K was filed by Ingevity Corporation on May 27, 2016. The report details compensation matters approved by the Compensation Committee following the Company's separation from WestRock Company. The filing focuses on the establishment of director compensation and various equity and cash incentive awards for named executive officers under the Ingevity Corporation 2016 Omnibus Incentive Plan.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It is a current report regarding corporate governance and executive compensation rather than a financial performance statement.
Material Changes and Compensation Details
Director Compensation
- Non-Employee Directors: Annual retainer of $75,000 plus $90,000 in Restricted Stock Units (RSUs) vesting in full on the first anniversary.
- Committee Chairs: Additional retainers of $50,000 (Board Chair), $15,000 (Audit Chair), and $10,000 each (Compensation and Nominating/Governance Chairs).
Executive Equity Awards
- Separation RSUs: Granted to CEO D. Michael Wilson (38,715 shares) and CFO John C. Fortson (29,036 shares) to replace WestRock agreements; vest ratably over three years.
- Replacement RSUs: Granted to executives to replace forfeited WestRock 2015 awards; vest in full on February 27, 2018.
- Service-Based RSUs: Granted to all named executives; vest ratably over three years (2017-2019).
- Stock Options: Granted with an exercise price of $27.38; vest in full on February 27, 2019, and expire on May 27, 2026.
- Performance-Based RSUs (PSUs): Target awards granted based on 2016-2018 Return on Invested Capital (ROIC) and cumulative Earnings Per Share (EPS). Payouts range from 0% to 200% of target.
Short-Term Incentives and Cash Awards
- Short-Term Incentive Plan: Funded based on adjusted EBITDA targets. No payout if performance is below 85% of target; maximum payout is 200% of target.
- Target Awards (2016): CEO ($800,000), CFO ($332,500), EVP Performance Chemicals ($240,000), General Counsel ($165,000), EVP Performance Materials ($137,500).
- Replacement Cash Awards: Granted to EVPs Rose ($111,111) and Woodcock ($48,611) to replace forfeited WestRock cash awards; vest in full on February 23, 2018.
- Verify the specific vesting schedules and cliff dates for the separation and replacement RSUs granted to the CEO and CFO.
- Confirm the definition of "adjusted EBITDA" and "adjusted EPS" used for performance calculations, specifically regarding the exclusion of non-recurring items.
- Review the full grant instruments for the Omnibus Plan, which are expected to be filed as exhibits to the second-quarter Form 10-Q.
- Monitor the Company's ability to meet the 2016-2018 performance thresholds required for PSU and short-term incentive payouts.
Guidance, Outlook, and Risks
The filing does not contain financial guidance or market outlook. The primary risk disclosed relates to the vesting conditions of performance-based awards, which are contingent on achieving specific ROIC and EPS targets over a three-year period (2016-2018). If actual performance falls below threshold levels, no vesting will occur for PSUs or short-term incentives.